— Know what they know.
Not Investment Advice

BNKL OTC

Bionik Laboratories Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Care Facilities · Tech Score Neutral · Power 49 · $1248 mcap · 735726 float · 0.072% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.0001
Volume578
Avg Volume528
Beta9.36
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORichard Paul Russo Jr.
Employees12
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date2015-03-05
80 Coolidge Hill Road
Watertown, MA 02472
US
617 926 4800
About Bionik Laboratories Corp.

Bionik Laboratories Corp. operates as a robotics firm, focusing on the innovation, development, and market introduction of advanced solutions for physical rehabilitation, prosthetic devices, and assistive robotics. The company's product range features the InMotion Robots, a comprehensive collection of robotic therapy tools. This includes the InMotion ARM, an intelligent and interactive therapeutic system grounded in scientific evidence, adept at perceiving patient movements and physical restrictions. Additionally, the InMotion ARM/HAND is offered to facilitate therapies requiring reaching with grasping and releasing actions, alongside individual hand manipulations. Rounding out their offerings is the InMotion Connect platform, which integrates a hardware unit that interfaces with an InMotion Robot, coupled with a subscription for the InMotion Connect Pulse service. Established in 2010, Bionik Laboratories Corp. maintains its principal operations in Watertown, Massachusetts.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
AUBERTON-HERVE ANDRE P-Purchase 1 $0.60 2023-06-13
Gaston-Dreyfus Remi C-Conversion 3,102,878 $0.60 2023-06-13
AUBERTON-HERVE ANDRE C-Conversion 186,111 $0.60 2023-06-13
Matine Charles P-Purchase 180,555 $0.60 2023-06-09
Gaston-Dreyfus Remi P-Purchase 180,555 $0.60 2023-06-09

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms